首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同剂量普伐他汀治疗急性冠脉综合症的临床效果分析
引用本文:黄仲略,谢彬,杨国康,金红艳,郭璠.不同剂量普伐他汀治疗急性冠脉综合症的临床效果分析[J].数理医药学杂志,2011,24(1):48-50.
作者姓名:黄仲略  谢彬  杨国康  金红艳  郭璠
作者单位:武汉科技大学附属汉阳医院心肺血管科,武汉,430050
摘    要:目的:观察不同剂量普伐他汀对急性冠脉综合征(ACS)患者调脂疗效及临床事件的影响。方法:103例入选的ACS患者按普伐他汀不同的剂量随机分为20 mg对照组和40mg治疗组,分别于服药后3、6月检测血脂水平、肝、肾及肌酸激酶功能,同时观察心脏不良事件(MACE)及药物不良反应发生率,所有病例均按时随访。结果:经过治疗,两组患者的TC、TG、LDL-C和HDL-C均有显著改善,差异有统计学意义(P<0.05)。治疗1年后,治疗组的MACE例数显著少于对照组,差异有统计学意义(P<0.05)。结论:普伐他汀40mg的调脂作用、安全性和减少急性冠脉综合征再住院率明显优于普伐他汀20mg。

关 键 词:普伐他汀  急性冠脉综合征  效果

Clinical Results Analysis of Pravastatin on Patients with Acute Coronary Syndrome
Huang Zhonglue,et al.Clinical Results Analysis of Pravastatin on Patients with Acute Coronary Syndrome[J].Journal of Mathematical Medicine,2011,24(1):48-50.
Authors:Huang Zhonglue  
Institution:Huang Zhonglue,et al(Department of cardiopulmonary,HanYang Hospital of Wuhan University of Scinence and Technology,Wuhan 430051)
Abstract:Objective: To study the effects of pravastatin on lipid-lowering therapy and heart events in patients with acute coronary syndrome.Methods: 103 patients who were selected with ACS were divided into two groups according to different doses of pravastatin: control group(20mg/d),treatment group(40mg/d).blood lipid、CK、BUN、CR、ALT were measured 3 months and 6 months after pravastatin treatment.At the same time adverse effects of heart events were observed.Results: After treatment,Two groups of patients with TC,TG,LDL-C and HDL-C were significantly improved,there was asignificant difference(P0.05).Conclusion: Pravastatin 40mg can adjust blood lipids,safety and decreasing re-admission incidence in acute coronary syndrome of more better than Pravastatin 20mg.
Keywords:pravastatin  acute coronary syndrome  results  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号